Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.
Bouguenina H, Salaun D, Mangon A, Muller L, Baudelet E, Camoin L, Tachibana T, Cianférani S, Audebert S, Verdier-Pinard P, Badache A.
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10687-E10696. doi: 10.1073/pnas.1705682114. Epub 2017 Nov 21.
Similar articles
Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
Verdier-Pinard P, Salaun D, Bouguenina H, Shimada S, Pophillat M, Audebert S, Agavnian E, Coslet S, Charafe-Jauffret E, Tachibana T, Badache A.
Sci Rep. 2017 Mar 24;7:44976. doi: 10.1038/srep44976.
Eribulin targets a ch-TOG-dependent directed migration of cancer cells.
Chanez B, Gonçalves A, Badache A, Verdier-Pinard P.
Oncotarget. 2015 Dec 8;6(39):41667-78. doi: 10.18632/oncotarget.6147.
ErbB2-dependent chemotaxis requires microtubule capture and stabilization coordinated by distinct signaling pathways.
Benseddik K, Sen Nkwe N, Daou P, Verdier-Pinard P, Badache A.
PLoS One. 2013;8(1):e55211. doi: 10.1371/journal.pone.0055211. Epub 2013 Jan 29.
Characterization of a human βV-tubulin antibody and expression of this isotype in normal and malignant human tissue.
Chao SK, Wang Y, Verdier-Pinard P, Yang CP, Liu L, Rodriguez-Gabin A, McDaid HM, Horwitz SB.
Cytoskeleton (Hoboken). 2012 Aug;69(8):566-76. doi: 10.1002/cm.21043. Epub 2012 Jul 2.
Tyrosine-dependent capture of CAP-Gly domain-containing proteins in complex mixture by EB1 C-terminal peptidic probes.
Calligaris D, Manatschal C, Marcellin M, Villard C, Monsarrat B, Burlet-Schiltz O, Steinmetz MO, Braguer D, Lafitte D, Verdier-Pinard P.
J Proteomics. 2012 Jun 27;75(12):3605-16. doi: 10.1016/j.jprot.2012.04.006. Epub 2012 Apr 21.
Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
Connolly D, Yang Z, Castaldi M, Simmons N, Oktay MH, Coniglio S, Fazzari MJ, Verdier-Pinard P, Montagna C.
Breast Cancer Res. 2011 Aug 10;13(4):R76. doi: 10.1186/bcr2924.
Septin roles in tumorigenesis.
Connolly D, Abdesselam I, Verdier-Pinard P, Montagna C.
Biol Chem. 2011 Aug;392(8-9):725-38. doi: 10.1515/BC.2011.073. Epub 2011 Jul 11. Review.
MALDI in-source decay of high mass protein isoforms: application to alpha- and beta-tubulin variants.
Calligaris D, Villard C, Terras L, Braguer D, Verdier-Pinard P, Lafitte D.
Anal Chem. 2010 Jul 15;82(14):6176-84. doi: 10.1021/ac100996v.
Methods in tubulin proteomics.
Miller LM, Xiao H, Burd B, Horwitz SB, Angeletti RH, Verdier-Pinard P.
Methods Cell Biol. 2010;95:105-26. doi: 10.1016/S0091-679X(10)95007-3. Review.
Microtubule targeting agents: from biophysics to proteomics.
Calligaris D, Verdier-Pinard P, Devred F, Villard C, Braguer D, Lafitte D.
Cell Mol Life Sci. 2010 Apr;67(7):1089-104. doi: 10.1007/s00018-009-0245-6. Epub 2010 Jan 28. Review.
Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation.
Xiao H, El Bissati K, Verdier-Pinard P, Burd B, Zhang H, Kim K, Fiser A, Angeletti RH, Weiss LM.
J Proteome Res. 2010 Jan;9(1):359-72. doi: 10.1021/pr900699a.
Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
Khrapunovich-Baine M, Menon V, Verdier-Pinard P, Smith AB 3rd, Angeletti RH, Fiser A, Horwitz SB, Xiao H.
Biochemistry. 2009 Dec 15;48(49):11664-77. doi: 10.1021/bi901351q.
Tubulin proteomics: towards breaking the code.
Verdier-Pinard P, Pasquier E, Xiao H, Burd B, Villard C, Lafitte D, Miller LM, Angeletti RH, Horwitz SB, Braguer D.
Anal Biochem. 2009 Jan 15;384(2):197-206. doi: 10.1016/j.ab.2008.09.020. Epub 2008 Sep 18. Review. No abstract available.
Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites.
Honoré S, Pagano A, Gauthier G, Bourgarel-Rey V, Verdier-Pinard P, Civiletti K, Kruczynski A, Braguer D.
Mol Cancer Ther. 2008 Jul;7(7):2080-9. doi: 10.1158/1535-7163.MCT-08-0156.
Increased levels of a unique post-translationally modified betaIVb-tubulin isotype in liver cancer.
Miller LM, Menthena A, Chatterjee C, Verdier-Pinard P, Novikoff PM, Horwitz SB, Angeletti RH.
Biochemistry. 2008 Jul 15;47(28):7572-82. doi: 10.1021/bi8005225. Epub 2008 Jun 21.
Aneuploidy acts both oncogenically and as a tumor suppressor.
Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW.
Cancer Cell. 2007 Jan;11(1):25-36. Epub 2006 Dec 28.
Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin.
Dabydeen DA, Burnett JC, Bai R, Verdier-Pinard P, Hickford SJ, Pettit GR, Blunt JW, Munro MH, Gussio R, Hamel E.
Mol Pharmacol. 2006 Dec;70(6):1866-75. Epub 2006 Aug 29.
Insights into the mechanism of microtubule stabilization by Taxol.
Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB, Orr GA.
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10166-10173. doi: 10.1073/pnas.0603704103. Epub 2006 Jun 26.
4,5-Diaryl-1H-pyrrole-2-carboxylates as combretastatin A-4/lamellarin T hybrids: synthesis and evaluation as anti-mitotic and cytotoxic agents.
Banwell MG, Hamel E, Hockless DC, Verdier-Pinard P, Willis AC, Wong DJ.
Bioorg Med Chem. 2006 Jul 1;14(13):4627-38. Epub 2006 Feb 28.
Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomics.
Verdier-Pinard P, Shahabi S, Wang F, Burd B, Xiao H, Goldberg GL, Orr GA, Horwitz SB.
Biochemistry. 2005 Dec 6;44(48):15858-70.
A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence.
Yang CP, Verdier-Pinard P, Wang F, Lippaine-Horvath E, He L, Li D, Höfle G, Ojima I, Orr GA, Horwitz SB.
Mol Cancer Ther. 2005 Jun;4(6):987-95.
Mechanisms of Taxol resistance related to microtubules.
Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB.
Oncogene. 2003 Oct 20;22(47):7280-95. Review.
Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry.
Verdier-Pinard P, Wang F, Burd B, Angeletti RH, Horwitz SB, Orr GA.
Biochemistry. 2003 Oct 21;42(41):12019-27.
Total synthesis of (+/-)-rhazinal, an alkaloidal spindle toxin from Kopsia teoi.
Banwell MG, Edwards AJ, Jolliffe KA, Smith JA, Hamel E, Verdier-Pinard P.
Org Biomol Chem. 2003 Jan 21;1(2):296-305.
Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry.
Verdier-Pinard P, Wang F, Martello L, Burd B, Orr GA, Horwitz SB.
Biochemistry. 2003 May 13;42(18):5349-57.
Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation.
Martello LA, Verdier-Pinard P, Shen HJ, He L, Torres K, Orr GA, Horwitz SB.
Cancer Res. 2003 Mar 15;63(6):1207-13.
Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
Ojo-Amaize EA, Nchekwube EJ, Cottam HB, Bai R, Verdier-Pinard P, Kakkanaiah VN, Varner JA, Leoni L, Okogun JI, Adesomoju AA, Oyemade OA, Hamel E.
Cancer Res. 2002 Jul 15;62(14):4007-14.
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
Marquez BL, Watts KS, Yokochi A, Roberts MA, Verdier-Pinard P, Jimenez JI, Hamel E, Scheuer PJ, Gerwick WH.
J Nat Prod. 2002 Jun;65(6):866-71.
Antifungal and cancer cell growth inhibitory activities of 1-(3',4',5'-trimethoxyphenyl)-2-nitro-ethylene.
Pettit RK, Hamel E, Verdier-Pinard P, Roberson RW, Hazen KC, Pettit GR, Crews LC.
Mycoses. 2002 Apr;45(3-4):65-74.
Design, synthesis, and biological evaluation of a series of lavendustin A analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin polymerization.
Mu F, Coffing SL, Riese DJ 2nd, Geahlen RL, Verdier-Pinard P, Hamel TE, Johnson J, Cushman M.
J Med Chem. 2001 Feb 1;44(3):441-52.
Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.
Pettit GR, Lippert JW 3rd, Boyd MR, Verdier-Pinard P, Hamel E.
Anticancer Drug Des. 2000 Oct;15(5):361-71.
[Combretastatin A4 phosphate].
Verdier-Pinard P, Lansiaux A, Bailly C.
Bull Cancer. 2001 Mar;88(3):235-9. Review. French. No abstract available.
A novel palladium-mediated coupling approach to 2,3-disubstituted benzo(b)thiophenes and its application to the synthesis of tubulin binding agents.
Flynn BL, Verdier-Pinard P, Hamel E.
Org Lett. 2001 Mar 8;3(5):651-4.
Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin.
Bai R, Verdier-Pinard P, Gangwar S, Stessman CC, McClure KJ, Sausville EA, Pettit GR, Bates RB, Hamel E.
Mol Pharmacol. 2001 Mar;59(3):462-9.
Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin.
Pinney KG, Mejia MP, Villalobos VM, Rosenquist BE, Pettit GR, Verdier-Pinard P, Hamel E.
Bioorg Med Chem. 2000 Oct;8(10):2417-25.
A steroid derivative with paclitaxel-like effects on tubulin polymerization.
Verdier-Pinard P, Wang Z, Mohanakrishnan AK, Cushman M, Hamel E.
Mol Pharmacol. 2000 Mar;57(3):568-75.
Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity.
Verdier-Pinard P, Kepler JA, Pettit GR, Hamel E.
Mol Pharmacol. 2000 Jan;57(1):180-7.
Differential in vitro association of vinca alkaloid-induced tubulin spiral filaments into aggregated spirals.
Verdier-Pinard P, Garès M, Wright M.
Biochem Pharmacol. 1999 Sep 15;58(6):959-71.
Biosynthesis of radiolabeled curacin A and its rapid and apparently irreversible binding to the colchicine site of tubulin.
Verdier-Pinard P, Sitachitta N, Rossi JV, Sackett DL, Gerwick WH, Hamel E.
Arch Biochem Biophys. 1999 Oct 1;370(1):51-8.
Curacin D, an antimitotic agent from the marine cyanobacterium Lyngbya majuscula.
Márquez B, Verdier-Pinard P, Hamel E, Gerwick WH.
Phytochemistry. 1998 Dec;49(8):2387-9.
Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
Pettit GR, Toki B, Herald DL, Verdier-Pinard P, Boyd MR, Hamel E, Pettit RK.
J Med Chem. 1998 May 7;41(10):1688-95.
Antitumor agents--CLXXV. Anti-tubulin action of (+)-thiocolchicine prepared by partial synthesis.
Shi Q, Verdier-Pinard P, Brossi A, Hamel E, Lee KH.
Bioorg Med Chem. 1997 Dec;5(12):2277-82.
Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.
Verdier-Pinard P, Lai JY, Yoo HD, Yu J, Marquez B, Nagle DG, Nambu M, White JD, Falck JR, Gerwick WH, Day BW, Hamel E.
Mol Pharmacol. 1998 Jan;53(1):62-76.
Antitumor agents. 172. Synthesis and biological evaluation of novel deacetamidothiocolchicin-7-ols and ester analogs as antitubulin agents.
Shi Q, Verdier-Pinard P, Brossi A, Hamel E, McPhail AT, Lee KH.
J Med Chem. 1997 Mar 14;40(6):961-6.
Differential in vitro action of S-12363, a new vinblastine derivative, and of its epimer on microtubule proteins.
Wright M, Garès M, Verdier-Pinard P, Moisand A, Berlion M, Legrand JJ, Bizzari JP.
Cancer Chemother Pharmacol. 1991;28(6):434-40.
Filters: Manage Filters